NCT05587205View on ClinicalTrials.gov

Study to Assess Safety and Tolerability of EO2002

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

July 30, 2025

Study Completion Date

December 1, 2025

Conditions
CataractEndothelial Cell Loss, Corneal
Interventions
BIOLOGICAL

EO2002

Intracameral injection of a single dose of magnetic human corneal endothelial cells (EO2002) either at the time of cataract surgery or post-cataract surgery

OTHER

Sham injection

Sham injection

Trial Locations (1)

04030

RECRUITING

Asociacion para Evitar la Ceguera en Mexico, Mexico City

Sponsors

Collaborators (1)

Emmecell
All Listed Sponsors
collaborator

Emmecell

INDUSTRY

lead

Asociación para Evitar la Ceguera en México

OTHER